SA
Create Free Alerts
Lincoln Educational Services CorporationLINCNASDAQ
Loading
OverviewIntelligenceChartsNews

Latest News

Lincoln Educational Services to Highlight Recent Success and Review Strategic Priorities at 38th Annual ROTH Conference
globenewswire.com

Lincoln Educational Services to Highlight Recent Success and Review Strategic Priorities at 38th Annual ROTH Conference

Parsippany, NJ, March 17, 2026 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) today announced that it will be participating at the Roth Annual Growth Conference, being held March 22-24 in Laguna Niguel, CA. Scott Shaw, President and CEO, along with Brian Meyers, Chief Financial Officer, will be meeting growth-oriented institutional investors to provide an overview of the Company, recent success and growth initiatives over the next few years.

Lincoln Educational Services Hosting Investor Day on March 19th
globenewswire.com

Lincoln Educational Services Hosting Investor Day on March 19th

PARSIPPANY, NJ, March 12, 2026 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) today announced that it will host an Investor Day conference at its new Nashville, TN campus, on Thursday, March 19, 2026, with presentations starting at 10:00 am CT (11am ET).  A video webcast of the presentations, along with a question-and-answer session with the Company's executive leaders and guests, will be livestreamed and will focus on Lincoln's strategic priorities and growth initiatives over the next five years, through 2030.

APEI or LINC: Which Is the Better Value Stock Right Now?
zacks.com

APEI or LINC: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Schools sector have probably already heard of American Public Education (APEI) and Lincoln Educational Services Corporation (LINC). But which of these two stocks presents investors with the better value opportunity right now?

Lincoln Educational: Solid Growth, Less Attractive Entry Point (Rating Downgrade)
seekingalpha.com

Lincoln Educational: Solid Growth, Less Attractive Entry Point (Rating Downgrade)

Lincoln Educational Services (LINC) has delivered strong enrollment growth, campus expansion, and margin improvements, with FY2025 revenue up 17.8% and EBITDA up 59%. LINC now trades at a substantial premium to education peers, with much of the upside from its expansion strategy priced in after a 263% stock increase over two years. Operational execution, continued enrollment growth, and capital intensity remain key risks, especially given elevated valuation and ongoing negative free cash flow.

Lincoln Educational Services Corporation Schedules Fourth Quarter and Year End 2025 Earnings Release and Conference Call
globenewswire.com

Lincoln Educational Services Corporation Schedules Fourth Quarter and Year End 2025 Earnings Release and Conference Call

PARSIPPANY, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) (“Lincoln”) announced today that it will host a conference call to discuss its fourth quarter and year-end financial results on Monday, February 23, 2026 at 10:00 a.m. Eastern time. A news release outlining Lincoln's results will be issued before 9:30 a.m. Eastern time on that day.

Lincoln Educational Services: Future Growth Offers Promise
seekingalpha.com

Lincoln Educational Services: Future Growth Offers Promise

Lincoln Educational Services demonstrates strong revenue and enrollment growth, with management projecting continued expansion through new campuses and programs. LINC guides 2025 revenue of $505–$510 million and EBITDA of $65–$67 million, with a 2027 revenue target raised to $600 million. Shares appear fairly valued on 2025 metrics and slightly expensive relative to peers, but forward projections suggest compelling annualized upside if targets are met.

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026
globenewswire.com

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026

Study conducted at US sites evaluates LumeeTM in peripheral artery disease (PAD) patients BERKELEY, Calif, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual's biochemistry, announces the presentation of positive US-study clinical trial results at Leipzig Interventional Course in Leipgzig, Germany on Wednesday, January 28, 2026.  The study, conducted at the University of California San Francisco, San Francisco VA Medical Center, and San Francisco General Hospital, showed Lumee oxygen tissue monitoring is a safe and effective method for long term monitoring of peripheral artery disease (PAD) patients.

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance